US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amaya

17.70

-0.2000-1.12%

Volume:121.22K

Turnover:2.15M

Market Cap:2.57B

PE:25.65

High:18.05

Open:17.90

Low:17.60

Close:17.90

Loading ...

Overview Company News Filings

CIBC Reaffirms Their Buy Rating on Aya Gold & Silver (AYA)

National Bank Sticks to Its Buy Rating for Aya Gold & Silver (AYA)

Petra Capital Sticks to Its Buy Rating for Artrya Limited (AYA)

Positive Report for Aya Gold & Silver (AYA) from Stifel Nicolaus

Aya Gold & Silver Up Nearly 15%, on Pace for Largest Percent Increase Since March 2022 -- Data Talk

Wedbush Reviews Fennec Pharmaceuticals' Q4

Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

CIBC Keeps Their Buy Rating on Aya Gold & Silver (AYA)

Desjardins Remains a Buy on Aya Gold & Silver (AYA)

Petra Capital Remains a Buy on Artrya Limited (AYA)

Fennec Pharmaceuticals Announces Commercial Launch of PEDMARQSI® In Germany

Neta X/AYA Listed in Singapore, New Store Opening Soon

National Bank Keeps Their Buy Rating on Aya Gold & Silver (AYA)

Stifel Nicolaus Reaffirms Their Buy Rating on Aya Gold & Silver (AYA)

Fennec Pharmaceuticals Announces Pedmarqsi® Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales

Stifel Nicolaus Reaffirms Their Buy Rating on Aya Gold & Silver (AYA)

Stifel Nicolaus Reaffirms Their Buy Rating on Aya Gold & Silver (AYA)

Fennec Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update

Fennec Pharmaceuticals Strengthens Executive Leadership Team with Three Key Appointments to Accelerate the Company’s Next Stage of Growth

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AYA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AYA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AYA\",,,,,undefined,":{"symbol":"AYA","market":"US","secType":"STK","nameCN":"Amaya","latestPrice":17.7,"timestamp":1501531200000,"preClose":17.9,"halted":4,"volume":121219,"delay":0,"floatShares":96630000,"shares":145101000,"eps":0.69,"marketStatus":"Delisted","change":-0.2,"latestTime":"07-31 16:00:00 EDT","open":17.9,"high":18.05,"low":17.6,"amount":2145576.3,"amplitude":0.02514,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.69,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":17.9,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AYA\",,,,,undefined,":{"symbol":"AYA","floatShares":96630000,"roa":"--","roe":"--","lyrEps":0,"shares":145101000,"dividePrice":0,"high":18.05,"amplitude":0.02514,"preClose":17.9,"low":17.6,"week52Low":12.85,"pbRate":"1.14","week52High":20.35,"institutionHeld":0,"latestPrice":17.7,"eps":0.69,"divideRate":0,"volume":121219,"delay":0,"ttmEps":0.69,"open":17.9},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AYA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529582905","title":"CIBC Reaffirms Their Buy Rating on Aya Gold & Silver (AYA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2529582905","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529582905?lang=en_us&edition=fundamental","pubTime":"2025-04-22 22:15","pubTimestamp":1745331334,"startTime":"0","endTime":"0","summary":"In a report released today, Cosmos Chiu from CIBC maintained a Buy rating on Aya Gold & Silver (AYA – Research Report), with a price target of C$22...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cibc-reaffirms-their-buy-rating-on-aya-gold-silver-aya?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cibc-reaffirms-their-buy-rating-on-aya-gold-silver-aya?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AYA"],"gpt_icon":0},{"id":"2524466394","title":"National Bank Sticks to Its Buy Rating for Aya Gold & Silver (AYA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2524466394","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524466394?lang=en_us&edition=fundamental","pubTime":"2025-04-03 04:06","pubTimestamp":1743624390,"startTime":"0","endTime":"0","summary":"In a report released today, Don DeMarco from National Bank maintained a Buy rating on Aya Gold & Silver (AYA – Research Report), with a price targe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/national-bank-sticks-to-its-buy-rating-for-aya-gold-silver-aya-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/national-bank-sticks-to-its-buy-rating-for-aya-gold-silver-aya-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AYA","NBHC"],"gpt_icon":0},{"id":"2524906706","title":"Petra Capital Sticks to Its Buy Rating for Artrya Limited (AYA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2524906706","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524906706?lang=en_us&edition=fundamental","pubTime":"2025-04-01 06:35","pubTimestamp":1743460525,"startTime":"0","endTime":"0","summary":"Petra Capital analyst Tanushree Jain maintained a Buy rating on Artrya Limited (AYA – Research Report) on March 28 and set a price target of A$2.26...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/petra-capital-sticks-to-its-buy-rating-for-artrya-limited-aya?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/petra-capital-sticks-to-its-buy-rating-for-artrya-limited-aya?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AYA"],"gpt_icon":0},{"id":"2520186154","title":"Positive Report for Aya Gold & Silver (AYA) from Stifel Nicolaus","url":"https://stock-news.laohu8.com/highlight/detail?id=2520186154","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520186154?lang=en_us&edition=fundamental","pubTime":"2025-03-19 20:17","pubTimestamp":1742386638,"startTime":"0","endTime":"0","summary":"In a report released today, Stephen Soock from Stifel Nicolaus upgraded Aya Gold & Silver (AYA – Research Report) to a Buy, with a price target of ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/positive-report-for-aya-gold-silver-aya-from-stifel-nicolaus?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/positive-report-for-aya-gold-silver-aya-from-stifel-nicolaus?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SF","AYA","BK4127"],"gpt_icon":0},{"id":"2518221477","title":"Aya Gold & Silver Up Nearly 15%, on Pace for Largest Percent Increase Since March 2022 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2518221477","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518221477?lang=en_us&edition=fundamental","pubTime":"2025-03-12 01:06","pubTimestamp":1741712760,"startTime":"0","endTime":"0","summary":"Aya Gold & Silver Inc.  is currently at C$11.63, up C$1.50 or 14.81%. --On pace for largest percent increase since March 21, 2022, when it rose 19.88%. --Down 39.52% from its all-time closing high of C$19.23 on Oct. 22, 2024. --Up 10.13% from 52 weeks ago , when it closed at C$10.56. --Up 14.81% from its 52-week closing low of C$10.13 on March 10, 2025. --Up 15.7% at today's intraday high; largest intraday percent increase since May 13, 2022, when it rose as much as 19.32%","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Aya Gold & Silver Up Nearly 15%, on Pace for Largest Percent Increase Since March 2022 -- Data Talk","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AYA"],"gpt_icon":0},{"id":"2518203348","title":"Wedbush Reviews Fennec Pharmaceuticals' Q4","url":"https://stock-news.laohu8.com/highlight/detail?id=2518203348","media":"MT Newswires","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518203348?lang=en_us&edition=fundamental","pubTime":"2025-03-11 00:46","pubTimestamp":1741625219,"startTime":"0","endTime":"0","summary":"Fennec Pharmaceuticals' fourth-quarter Pedmark revenue of US$7.9 million beat Wedbush's US$7.6 million estimate. Initiatives are in place to drive Pedmark growth, including the continued penetration of the adolescent and young adult  population.Management commentary on early AYA adoption is encouraging, given that the community treated AYA population is a larger and more lucrative  patient population compared to the in-patient pediatric population, Wedbush said.Fennec expects its growth initiatives to result in a significant inflection beginning in the second half of this year. Outside the U.S., partner Norgine recently launched Pedmarqsi in the UK and Germany.Topline data from the Japanese trial of Pedmark in children and AYAs are expected in the second half of this year with a potential registration or licensing deal in Japan to follow. In Turkey and Gulf Cooperation Council Countries, Fennec has partnered with distributor Inpharmus.Fennec is rated Outperform, with a US$13 target.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/wedbush-reviews-fennec-pharmaceuticals-apos-164659234.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["FENC","BK4139","AYA"],"gpt_icon":0},{"id":"2518320243","title":"Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2518320243","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518320243?lang=en_us&edition=fundamental","pubTime":"2025-03-10 18:03","pubTimestamp":1741600980,"startTime":"0","endTime":"0","summary":"~ Achieved Full-Year PEDMARKNet Product Sales of $29.6 Million, Up 40% Year-Over-Year, and Generated PEDMARK Q4 2024 Net Product Sales of $7.9 Million ~ ~ Delivered Q4 2024 EBITDA Loss of $0.6 Million","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/10/3039528/0/en/Fennec-Pharmaceuticals-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","BK4139","BK4213","FENC","GFR","BK4566","NICE","AYA","BK4543","IE00BFMHRM44.USD"],"gpt_icon":0},{"id":"2514013503","title":"CIBC Keeps Their Buy Rating on Aya Gold & Silver (AYA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514013503","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514013503?lang=en_us&edition=fundamental","pubTime":"2025-02-25 22:58","pubTimestamp":1740495531,"startTime":"0","endTime":"0","summary":"CIBC analyst Cosmos Chiu maintained a Buy rating on Aya Gold & Silver (AYA – Research Report) today and set a price target of C$23.00. The company’...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cibc-keeps-their-buy-rating-on-aya-gold-silver-aya?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cibc-keeps-their-buy-rating-on-aya-gold-silver-aya?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AYA"],"gpt_icon":0},{"id":"2511574262","title":"Desjardins Remains a Buy on Aya Gold & Silver (AYA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2511574262","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511574262?lang=en_us&edition=fundamental","pubTime":"2025-02-14 04:06","pubTimestamp":1739477167,"startTime":"0","endTime":"0","summary":"Desjardins analyst Allison Carson CFA maintained a Buy rating on Aya Gold & Silver (AYA – Research Report) today and set a price target of C$23.00....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/desjardins-remains-a-buy-on-aya-gold-silver-aya?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/desjardins-remains-a-buy-on-aya-gold-silver-aya?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AYA","CFA"],"gpt_icon":0},{"id":"2510654005","title":"Petra Capital Remains a Buy on Artrya Limited (AYA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2510654005","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510654005?lang=en_us&edition=fundamental","pubTime":"2025-02-10 11:05","pubTimestamp":1739156746,"startTime":"0","endTime":"0","summary":"In a report released on February 6, Tanushree Jain from Petra Capital maintained a Buy rating on Artrya Limited (AYA – Research Report), with a pri...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/petra-capital-remains-a-buy-on-artrya-limited-aya?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/petra-capital-remains-a-buy-on-artrya-limited-aya?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AYA"],"gpt_icon":0},{"id":"2509712105","title":"Fennec Pharmaceuticals Announces Commercial Launch of PEDMARQSI® In Germany","url":"https://stock-news.laohu8.com/highlight/detail?id=2509712105","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509712105?lang=en_us&edition=fundamental","pubTime":"2025-02-07 20:00","pubTimestamp":1738929600,"startTime":"0","endTime":"0","summary":"~ PEDMARQSIis the First and Only Approved Therapy in the EU andU.K.for the Prevention of Ototoxicity, or Hearing Loss, Induced by Cisplatin Chemotherapy in Patients 1 month to <18 Years of Age with Localized, Non-Metastatic Solid Tumors ~~ Norgine Pharmaceuticals’ Launch of PEDMARQSIin Germany Accelerates Global Commercialization Strategy ~PEDMARQSIis the first and only approved therapy in the EU and U.K. for the prevention of ototoxicity, or hearing loss, induced by cisplatin chemotherapy in patients 1 month to <18 years of age with localized, non-metastatic solid tumors. PEDMARQSI was granted marketing authorization by the European Commission in June 2023 under the paediatric-use marketing authorization , which includes 8 years plus 2 years of data and market protection.Cisplatin and other platinum compounds are essential chemotherapeutic agents for the treatment of many pediatric malignancies. Unfortunately, platinum-based therapies can cause ototoxicity, or hearing loss, which is p","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fennec-pharmaceuticals-announces-commercial-launch-120000927.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["FENC","BK4213","GFR","AYA","BK4139"],"gpt_icon":0},{"id":"2502385106","title":"Neta X/AYA Listed in Singapore, New Store Opening Soon","url":"https://stock-news.laohu8.com/highlight/detail?id=2502385106","media":"Pandaily","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502385106?lang=en_us&edition=fundamental","pubTime":"2025-01-10 17:54","pubTimestamp":1736502844,"startTime":"0","endTime":"0","summary":"\nNeta X/AYA is listed in Singapore, and the new store will open in Singapore shortly.\n","market":"sg","thumbnail":"https://assets.pandaily.com/uploads/2022/12/3-10.jpg","type":0,"news_type":0,"thumbnails":["https://assets.pandaily.com/uploads/2022/12/3-10.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://pandaily.com/neta-x-aya-listed-in-singapore-new-store-opening-soon/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"pandaily_highlight","symbols":["NEV","AYA"],"gpt_icon":0},{"id":"2502021974","title":"National Bank Keeps Their Buy Rating on Aya Gold & Silver (AYA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2502021974","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502021974?lang=en_us&edition=fundamental","pubTime":"2025-01-10 04:05","pubTimestamp":1736453124,"startTime":"0","endTime":"0","summary":"In a report released today, Don DeMarco from National Bank maintained a Buy rating on Aya Gold & Silver (AYA – Research Report), with a price targe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/national-bank-keeps-their-buy-rating-on-aya-gold-silver-aya?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/national-bank-keeps-their-buy-rating-on-aya-gold-silver-aya?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AYA","NBHC"],"gpt_icon":0},{"id":"2501016922","title":"Stifel Nicolaus Reaffirms Their Buy Rating on Aya Gold & Silver (AYA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2501016922","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501016922?lang=en_us&edition=fundamental","pubTime":"2025-01-07 21:35","pubTimestamp":1736256916,"startTime":"0","endTime":"0","summary":"In a report released today, Stephen Soock from Stifel Nicolaus maintained a Buy rating on Aya Gold & Silver (AYA – Research Report), with a price t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-reaffirms-their-buy-rating-on-aya-gold-silver-aya-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-reaffirms-their-buy-rating-on-aya-gold-silver-aya-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SF","AYA"],"gpt_icon":0},{"id":"2492416656","title":"Fennec Pharmaceuticals Announces Pedmarqsi® Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales","url":"https://stock-news.laohu8.com/highlight/detail?id=2492416656","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492416656?lang=en_us&edition=fundamental","pubTime":"2024-12-20 19:16","pubTimestamp":1734693360,"startTime":"0","endTime":"0","summary":"~ PEDMARQSI(anhydrous sodium thiosulfate) is the first and only treatment available within NHS England and Wales for the prevention of cisplatin-induced ototoxicity (hearing loss) in children and youn","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/20/3000452/0/en/Fennec-Pharmaceuticals-Announces-Pedmarqsi-Positive-Recommendation-by-NICE-for-the-Prevention-of-Cisplatin-Induced-Hearing-Loss-in-England-and-Wales.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AYA","BK4023","GFR","IE00BFMHRM44.USD","BK4566","NICE","FENC","BK4213","BK4139"],"gpt_icon":0},{"id":"2484138591","title":"Stifel Nicolaus Reaffirms Their Buy Rating on Aya Gold & Silver (AYA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2484138591","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484138591?lang=en_us&edition=fundamental","pubTime":"2024-11-20 20:45","pubTimestamp":1732106737,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus analyst Stephen Soock maintained a Buy rating on Aya Gold & Silver (AYA – Research Report) today and set a price target of C$23.00....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-reaffirms-their-buy-rating-on-aya-gold-silver-aya-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-reaffirms-their-buy-rating-on-aya-gold-silver-aya-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SF","AYA"],"gpt_icon":0},{"id":"2483378742","title":"Stifel Nicolaus Reaffirms Their Buy Rating on Aya Gold & Silver (AYA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2483378742","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483378742?lang=en_us&edition=fundamental","pubTime":"2024-11-15 20:57","pubTimestamp":1731675444,"startTime":"0","endTime":"0","summary":"In a report released today, Stephen Soock from Stifel Nicolaus maintained a Buy rating on Aya Gold & Silver (AYA – Research Report), with a price t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-reaffirms-their-buy-rating-on-aya-gold-silver-aya-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-reaffirms-their-buy-rating-on-aya-gold-silver-aya-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SF","AYA"],"gpt_icon":0},{"id":"2481974836","title":"Fennec Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2481974836","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481974836?lang=en_us&edition=fundamental","pubTime":"2024-11-07 19:13","pubTimestamp":1730977980,"startTime":"0","endTime":"0","summary":"~ Achieved Third Quarter 2024 Net Product Sales of $7.0 Million ~ ~ Increasing Momentum and Successful Reimbursement in the Adolescent and Young Adult (AYA) Segment Following Strategic Investments to ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/07/2976433/0/en/Fennec-Pharmaceuticals-Reports-Third-Quarter-2024-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AYA","FENC","GFR","BK4139","BK4213"],"gpt_icon":0},{"id":"2478170768","title":"Fennec Pharmaceuticals Strengthens Executive Leadership Team with Three Key Appointments to Accelerate the Company’s Next Stage of Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2478170768","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478170768?lang=en_us&edition=fundamental","pubTime":"2024-10-28 18:23","pubTimestamp":1730110980,"startTime":"0","endTime":"0","summary":"~ Pierre S. Sayad, PhD, M.S., Appointed Chief Medical Officer ~ ~ Terry Evans Appointed Chief Commercial Officer ~ ~ Christiana Cioffi, MBA, Appointed Chief Strategy Officer ~ RESEARCH TRIANGLE PARK, ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/28/2969910/0/en/Fennec-Pharmaceuticals-Strengthens-Executive-Leadership-Team-with-Three-Key-Appointments-to-Accelerate-the-Company-s-Next-Stage-of-Growth.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FENC","BK4139","BK4213","BK4120","GFR","SSI","AYA","TISI","AAQC"],"gpt_icon":1}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":19,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AYA\",params:#limit:5,,,undefined,":[{"date":"2017-08-01","symbol":"AYA","newSymbol":"TSG","type":"symbolChange","dateTimestamp":1501560000000},{"market":"US","date":"2017-05-12","symbol":"AYA","fiscalQuarterEnding":null,"expectedEps":0.51,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1494561600000,"reportTimeType":"pre","actualEps":0.56},{"market":"US","date":"2016-11-14","symbol":"AYA","fiscalQuarterEnding":null,"expectedEps":0.38,"name":null,"time":"","type":"earning","dateTimestamp":1479099600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2016-08-12","symbol":"AYA","fiscalQuarterEnding":null,"expectedEps":0.36,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1470974400000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2016-05-16","symbol":"AYA","fiscalQuarterEnding":null,"expectedEps":0.31,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1463371200000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AYA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AYA\",market:\"US\",delay:false,,,undefined,":{}}}